INSM Q4 2019 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$46M+364.7% YoY

Gross Profit

$37M81.0% margin

Operating Income

-$47M-103.0% margin

Net Income

-$53M-115.9% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

+17.5%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$57M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$742M

Total Liabilities

$481M

Stockholders' Equity

$262M

Cash & Equivalents

$487M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$10M	+364.7%
Gross Profit	$37M	$0	—
Operating Income	-$47M	-$88M	+46.3%
Net Income	-$53M	-$92M	+42.1%